Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Nateglinide and mitiglinide].

Masato Odawara1

  • 1Department of Endocrinology and Metabolism, Toranomon Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 25, 2003
PubMed
Summary

Lowering post-prandial glucose in type 2 diabetes may prevent cardiovascular issues. Nateglinide, a medication, shows promise in managing post-meal hyperglycemia and potentially reducing cardiovascular event risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for gestational diabetes mellitus and postpartum glucose intolerance: a retrospective study from a hospital specializing in infertility treatment.

Scientific reports·2025
Same author

Prevention of Worsening Diabetes through Behavioral Changes by an IoT-based Self-Monitoring System in Japan (PRISM-J): Study design and rationale for a multicenter, open-label, randomized parallel-group trial.

GHM open·2025
Same author

Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial.

Journal of diabetes investigation·2024
Same author

Predictive patterns of lower urinary tract symptoms and bacteriuria in adults with type 2 diabetes.

Diabetology international·2024
Same author

Alternative splicing events as peripheral biomarkers for motor learning deficit caused by adverse prenatal environments.

Proceedings of the National Academy of Sciences of the United States of America·2023
Same author

Changes in lifestyle-related behaviour during the COVID-19 pandemic in Japan: a questionnaire survey for examinees who underwent an annual health check-up.

The Journal of international medical research·2023

Area of Science:

  • Endocrinology
  • Cardiology
  • Pharmacology

Background:

  • Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance and/or impaired insulin secretion.
  • Japanese T2DM patients often exhibit poorer insulin response post-glycemic load compared to Caucasians.
  • Post-challenge hyperglycemia is an independent risk factor for cardiovascular complications.

Purpose of the Study:

  • To evaluate the potential of targeting post-prandial hyperglycemia for cardiovascular event prevention in T2DM.
  • To assess the role of nateglinide in mitigating post-prandial glycemic surges and its cardiovascular implications.

Main Methods:

  • Review of existing observations and clinical trial results (e.g., STOP-NIDDM trial).
  • Analysis of nateglinide's pharmacokinetic and pharmacodynamic profile.
  • Examination of nateglinide's additive hypoglycemic effects with other antidiabetic agents.

Main Results:

  • Lowering post-prandial plasma glucose may offer protection against cardiovascular diseases.
  • Nateglinide effectively attenuates post-prandial glycemic surges in T2DM patients.
  • Nateglinide is associated with minimal weight gain and low risk of hypoglycemia, with additive effects alongside metformin or alpha-glucosidase inhibitors.

Conclusions:

  • Targeting post-prandial hyperglycemia is a viable strategy for cardiovascular risk reduction in T2DM.
  • Nateglinide demonstrates potential as a therapeutic agent for managing post-prandial hyperglycemia and may contribute to cardiovascular protection.

Related Experiment Videos